Title |
Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation
|
---|---|
Published in |
Pediatric Nephrology, December 2010
|
DOI | 10.1007/s00467-010-1708-6 |
Pubmed ID | |
Authors |
Samhar I. Al-Akash, P. Stephen Almond, Van H. Savell, Salam I. Gharaybeh, Cris Hogue |
Abstract |
A 15-year-old male patient developed atypical hemolytic uremic syndrome (aHUS) at 16 months of age leading to end-stage renal disease. The family history was suggestive of autosomal dominant aHUS, and he was more recently found to have a C3 heterozygous gene mutation (1835C>T mutation in exon 14, which determines the amino-acidic substitution R570W) with no other complement abnormalities. He had two renal transplants, the first at 2.5 years, and the second at 8 years of age, but allograft dysfunction developed in both transplants leading to graft failure due to recurrent HUS at 5 years and 18 months post-transplantation respectively. At 15 years of age he received a third transplant from a deceased donor with pre-emptive plasmapheresis. He had immediate graft function and nadir serum creatinine was 1.3-1.4 mg/dl. Severe allograft dysfunction and hypertension developed 2 months after transplantation following influenza infection. Renal allograft biopsy showed thrombotic microangiopathy. He received plasmapheresis followed by eculizumab therapy. Allograft function returned to baseline 3 weeks after starting therapy, and post-treatment allograft biopsies showed improvement in thrombotic microangiopathy. He continues to receive eculizumab every 2 weeks with stable graft function 13 months after transplantation. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Malaysia | 1 | 1% |
Spain | 1 | 1% |
Czechia | 1 | 1% |
Unknown | 73 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 16 | 21% |
Other | 12 | 16% |
Researcher | 10 | 13% |
Student > Postgraduate | 8 | 11% |
Librarian | 5 | 7% |
Other | 16 | 21% |
Unknown | 9 | 12% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 45 | 59% |
Pharmacology, Toxicology and Pharmaceutical Science | 7 | 9% |
Biochemistry, Genetics and Molecular Biology | 4 | 5% |
Agricultural and Biological Sciences | 4 | 5% |
Nursing and Health Professions | 2 | 3% |
Other | 5 | 7% |
Unknown | 9 | 12% |